Latisse® is getting all the buzz these days. Latisse® is the first FDA approved drug specifically indicated to promote eyelash growth. Allergan the makers of Botox® and Juvederm®, also make Latisse®. According to Allergan, Latisse® users can expect to experience longer, fuller, and darker eyelashes in as little as eight weeks, with full results in 16 weeks.  No wonder everyone wants it. Once Latisse® is stopped, eyelashes will slowly return to their pre-treatment appearance. The prescription requires a brief medical evaluation from a physician to make certain there are no contraindications.

Latisse® FAQ

  • Why everyone wants it:

    Beautiful long eyelashes have always been highly desired by women across cultures. Their presence creates a warm, feminine quality that universally warms and enhances the intrinsic beauty of the eyes. For years, a variety of mascara products have been put on the market to create this attractive look. Today, Latisse®, the first FDA approved drug specifically indicated to promote eyelash growth is giving mascara a run for its money. In 8-16 weeks of use, users will experience fuller, longer, and darker eyelashes without the need for mascara. IT REALLY WORKS!

  • Safety and Side Effects:

    Even though Latisse® is used for cosmetic enhancement of the upper eyelashes, it is not mascara. It is a FDA approved medical drug that is manufactured by Allergan, the makers of Botox and Juvederm, specifically indicated for creating longer, thicker, and darker eyelashes. According to Allergan, Latisse® was well-tolerated in its clinical trials, with the most common side effects being eye redness, itchy eyes, and very rarely temporary skin hyperpigmentation. Most of these are reversible once it is stopped. The overall, side effect rate is 4% according the Allergan but far less in our patient population especially when applied meticulously. In order to know if Latisse® is right for you, it is required that all new users have an evaluation by a physician. Certain drugs, eye drops, and eye conditions can increase the risk of other side effects although the active drug in Latisse® has been used safely in ophthalmology for many years.